PMS-Pazopanib 200 mg tablet; Presence of Sorafenib
Issued May 31, 2023
Issue
Presence of Sorafenib in affected lots.
Hazard description
Product quality
What to do
Verify if your product is affected. Contact the recalling firm if you have any questions about the recall. Report any health product related side effects to Health Canada. Report any other health product safety complaints to Health Canada.
Product
Product name
PMS-Pazopanib 200 mg tablet
Reference
ID
RA-73740
Get notified of similar recallsEnter your email to receive alerts when new recalls are issued by the same agency.
Subscribed. You'll get an email when new recalls are issued.
RecallTracker